Markus G. Blaurock
Greifswald, MV 17475, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Human host factors Secretory leukocyte protease inhibitor and Annexin A2 modulate the presence of human papillomavirus DNA, but not Epstein-Barr virus, in nasopharyngeal carcinoma from non-endemic regions.
Journal: Cancer treatment and research communications
Published: April 02, 2026
Malnutrition in gastrointestinal cancer manifests before systemic therapy and is associated with fatigue and reduced physical quality of life.
Journal: The oncologist
Published: November 08, 2025
Movement Behaviors and the Role of Self-Reported Symptoms and Well-Being: A Dynamic Structural Equation Modeling Approach Among Head and Neck Cancer Patients.
Journal: Psycho-oncology
Published: September 05, 2025
Use of AI during creation of scientific reviews: the example of sarcopenia in head and neck cancer
Journal: HNO
Published: August 07, 2025
Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study.
Journal: Biomedicines
Published: March 31, 2025
Individualized home training in head and neck cancer patients is safe and has positive short- and medium-term effects -results of a multicenter, single-arm intervention trial (OSHO #94).
Journal: Frontiers in oncology
Published: March 29, 2025
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.
Journal: NPJ precision oncology
Published: December 09, 2024
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial.
Journal: Med (New York, N.Y.)
Published: October 30, 2024
Last Updated: 09/26/2026